Tenaya Therapeutics, Inc.

NASDAQ:TNYA

Biotechnology

Healthcare
$0.31 -0.58%

-$0.00 today

Market cap
$69.95M
Beta
2.82
P/E (TTM)
-1.3
EPS (TTM)
-$0.54
52W Low $0.53High $2.35

Volume 2.77M

Average 3.79M

Balance Sheet

Inspect the capital base behind the business.

Assets

$146.92M

FY 2025 · Annual

+22.5% YoY

Liabilities

$23.66M

FY 2025 · Annual

-12.7% YoY

Equity

$123.27M

FY 2025 · Annual

+32.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents38.13M95.27M45.68M4.32M100.55M
Short-term Investments213.17M91.26M58.96M57.12M0
Net Receivables02.25M000
Inventory00000
Other Current Assets4.06M938K1.16M842K1.03M
Total Current Assets255.36M193.75M111.58M67.38M105.59M
Property, Plant & Equipment (Net)54.71M62.7M53.26M47.75M37.09M
Goodwill00000
Intangible Assets00000
Long-term Investments547K17.7M00419K
Tax Assets2.46M0000
Other Non-current Assets3.58M4.79M5.68M4.82M3.83M
Total Non-current Assets61.29M85.19M58.93M52.57M41.34M
Total Assets316.65M278.95M170.52M119.94M146.92M
Account Payables10.72M9.58M5.63M5.16M3.58M
Short-term Debt1.99M002.78M0
Tax Payables000348K0
Deferred Revenue00000
Other Current Liabilities5.39M6.97M9.27M5.81M6.19M
Total Current Liabilities21.77M24.25M22.73M15.98M15.44M
Long-term Debt00007.81M
Deferred Tax Liabilities2.46M0000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities182K228K253K281K410K
Total Non-current Liabilities16.35M11.32M8.36M11.11M8.22M
Total Liabilities38.12M35.57M31.09M27.09M23.66M
Common Stock4K7K7K8K21K
Retained Earnings(155.53M)(279.2M)(403.28M)(514.41M)(605.01M)
Accumulated OCI(141K)(378K)(106K)28K0
Other Stockholders Equity00000
Minority Interest00000
Total Equity278.53M243.38M139.42M92.85M123.27M
Total Debt15.7M15.1M12.42M13.61M10.83M
Net Debt(22.43M)(80.17M)(33.26M)9.29M(89.72M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$80.9M
Receivables$10.6M
Other Current$5.0M
Total Current Assets$96.6M
PP&E (Net)$34.7M
Other Non-current$3.8M
Total Non-current Assets$38.5M
Total Assets$135.1M

Analysis

Selected assets total $135.1M for Latest. The largest visible component is Cash & Equivalents at $80.9M, about 59.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
DEF 14ADEF 14A filingOct 23, 2026
DEFA14ADEFA14A filingOct 23, 2026
PRE 14APRE 14A filingOct 13, 2026

How much cash does TNYA have?

Tenaya Therapeutics, Inc. (TNYA) reported $100.55M in cash and equivalents in fiscal 2025.

How much debt does TNYA carry?

Tenaya Therapeutics, Inc. (TNYA) reported $10.83M of total debt, with net debt of -$89.72M.